How a Welsh pharmacy chain gained829 private patients in 12 months

The pharmacy’s starting point was a limited online presence and a heavy reliance on word of mouth. That left the business with an ambition to grow private services, but without a structured digital route to reach more prospective patients. Investing in the flagship site had created a platform for the private clinic offering. The marketing challenge was to make that offering easier to discover and connect interest in individual treatments with a relevant next step.

There was also no paid advertising strategy or conversion tracking. Without that measurement, the team lacked a clear way to judge which activity generated new patients and which services were responding best. More visibility alone would not resolve that gap: the work needed to connect service pages, advertising and patient acquisition.

The objective was therefore twofold: build a stronger digital presence for the pharmacy’s private services and make the resulting growth measurable. Local SEO, paid campaigns and landing pages needed to work together, rather than as isolated activities. The starting material does not establish a numerical baseline for bookings or a financial cost for missed opportunities, so this case study reports the measured campaign outcomes rather than an unsupported percentage uplift.

Over 12 months, the pharmacy gained 829 new private patients across the four services. Travel health delivered the largest patient total, with 353 acquisitions at a reported cost per acquisition of £11.24. Ear wax removal brought in 191 patients at £12.20, while flu vaccinations generated 188 at £4.28. Aesthetics added a further 97 patients at £14.80. Together, these figures show private patient growth spread across several treatments, rather than concentrated in a single service.

Flu vaccinations recorded the lowest cost per acquisition, while travel health contributed the greatest patient volume. Those are different measures of performance, and both are useful when reviewing pharmacy marketing results. The outcome gives the pharmacy evidence to inform its next investment decisions and a measurable basis for continuing to grow its private clinic offering. This addresses the original measurement gap: instead of relying on word of mouth without a clear acquisition picture, the team could review patient totals and reported acquisition costs for each of the four services. The reporting period is 12 months; it does not establish when the first patient was acquired or provide a month-by-month growth curve. These acquisition figures are not a published breakdown of revenue or profit, and they should not be read as a guarantee of the same results for another pharmacy.